Ragwitek — Medica
short ragweed pollen-induced allergic rhinitis with or without conjunctivitis
Initial criteria
- Patient is age ≥ 5 years
- Ragwitek therapy is initiated 12 weeks prior to the expected onset of the short ragweed pollen season
- Diagnosis is confirmed by ONE of the following: (i) positive skin test response to short ragweed pollen OR (ii) positive in vitro test (blood test) for allergen-specific immunoglobulin E antibodies for short ragweed pollen
Approval duration
1 year